1. Home
  2. Funding Opportunities

NIH Obesity Research Funding Opportunities

Current Opportunities Past Opportunities

Current Funding Opportunities

  1. Notice of Intent to Publish a Funding Opportunity Announcement for Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite (UG3/UH3) with Coordinating Center (U24)

    NOT-HL-20-820

  2. NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)

    RFA-DK-20-024

  3. Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children

    NOT-DK-20-036

  4. Notice of Special Interest (NOSI): Obesity Policy Evaluation Research (R01 Clinical Trial Not Allowed)

    NOT-DK-20-035

  5. Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)

    RFA-DK-20-021

  6. Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable

    NOT-MD-20-022

  7. Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences

    NOT-OD-20-097

  8. Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required)

    PAR-20-133

  9. Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required)

    PAR-20-134

  10. Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)

    RFA-AG-21-016

  11. Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required)

    RFA-DK-20-501

  12. Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required)

    RFA-DK-20-502

  13. Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)

    RFA-CA-20-004

  14. Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)

    RFA-CA-20-005

  15. Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31)

    PAR-19-378

  16. Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32)

    PAR-19-379

  17. Notice of Special Interest (NOSI): Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development 

    NOT-HL-19-695

  18. Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) 

    RFA-DK-19-004

  19. Notice of Special Interest in Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development 

    NOT-DK-19-007

  20. Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required) 

    PAR-18-924

  21. Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required) 

    PAR-18-925

  22. Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)

    PAR-18-898

  23. Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

    PAR-18-892

  24. Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) 

    PAR-18-893

  25. New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)

    PAR-18-886

  26. Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) 

    PA-18-856

  27. Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) 

    PAR-18-857

  28. Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) 

    PAR-18-854

  29. The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed) 

    PA-18-784

  30. Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)

    PA-18-776

  31. Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) 

    PA-18-741

  32. Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)

    PA-18-529

  33. Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed) 

    PA-18-531

  34. Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed) 

    PA-18-532

  35. Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional) 

    PA-18-379

  36. Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21 Clinical Trial Optional) 

    PA-18-354

  37. Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01 Clinical Trial Optional) 

    PA-18-355

  38. Investigator-Initiated Clinical Trials Targeting Diseases within the Mission of NIDDK (R01Clinical Trial Required) 

    PA-18-330